APOA1 and atherosclerosis: Indeed, it was shown that plasma of patients heterozygous for apoA-I[K107del] was lacking larger HDL2 subfractions and contained mostly smaller HDL3 subfractions (18), thereby increasing the patients' risk for atherosclerosis and CVD.